
|Videos|April 9, 2021
Treatment considerations in node-positive prostate cancer
Author(s)Urology Times staff
Advertisement
Jason Zhu, MD, a medical oncologist at Levine Cancer Institute, part of Atrium Health, discusses factors he considers when choosing treatment for patients with lymph node–positive prostate cancer after prostatectomy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
2
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
5










